Aiomax Medico Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
- Paid Up Capital ₹ 3.05 M
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.10 Cr
- Revenue Growth %
- Profit Growth 1046.49%
- Ebitda 4462.86%
- Net Worth 21.29%
- Total Assets 740.61%
About Aiomax Medico
Aiomax Medico Private Limited (AMPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 April 2017 (Seven years and ten months 9 days old ). Its registered office is in Varanasi, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 3.05 M.
The company currently has active open charges totaling ₹1.10 Cr.
Anand Rai, Abhishek Rai, and Shalini Rai serve as directors at the Company.
Company Details
- Location
Varanasi, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999UP2017PTC092224
- Company No.
092224
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Apr 2017
- Date of AGM
31 Oct 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Aiomax Medico?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Rai  | Director | 13-Apr-2017 | Current |
| Abhishek Rai | Director | 13-Apr-2017 | Current |
| Shalini Rai | Director | 13-Apr-2017 | Current |
Financial Performance of Aiomax Medico.
Aiomax Medico Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1046.49% increase in profit. The company's net worth Soared by an impressive increase of 21.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aiomax Medico?
In 2019, Aiomax Medico had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹11.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Apr 2020 | Others | ₹1.00 M | Open |
| 24 Aug 2018 | Others | ₹1.00 Cr | Open |
How Many Employees Work at Aiomax Medico?
Unlock and access historical data on people associated with Aiomax Medico, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aiomax Medico, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aiomax Medico's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.